Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 19,500 |
2 mg | 在庫あり | ¥ 28,500 |
5 mg | 在庫あり | ¥ 45,500 |
10 mg | 在庫あり | ¥ 75,500 |
25 mg | 在庫あり | ¥ 152,000 |
50 mg | 約6-8 週間 | ¥ 228,000 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 49,500 |
説明 | AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes. |
ターゲット&IC50 | GK:60 nM (EC50) |
別名 | AZD 1656 |
分子量 | 478.5 |
分子式 | C24H26N6O5 |
CAS No. | 919783-22-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (522.47 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD-1656 919783-22-5 Metabolism Glucokinase Hexokinase IV AZD1656 G6pc G6P ChREBP-β hypoglycemia AZD 1656 inhibit Inhibitor Hexokinase D epinephrine glucagon antihyperglycemic inhibitor